fbpx
Medical Innovation Exchange

In a rare rebuke, FDA refuses to fully review Aeglea's rare disease drug application

https://www.fiercebiotech.com/biotech/rare-refusal-file-rebuke-fda-declines-aegleas-rare-disease-drug-application

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.